Prometheus: Bound For Clarification Or Confusion?

Law360, New York (July 13, 2011, 1:23 PM EDT) -- On June 20, 2011, the U.S. Supreme Court granted certiorari for the second time in Prometheus Labs. Inc. v. Mayo Collaborative Servs., after having already granted certiorari last year, vacating and remanding to the Federal Circuit for further consideration in light of Bilski. The patent claims at issue in Prometheus are medical method claims directed at administering a drug to treat autoimmune disorders, and determining whether the metabolite level of the drug falls within a range correlated with efficacy but not toxicity....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!